CLINICAL_TRIALS ClinicalTrials.gov record update

Double-blind,Randomized,Controlled,Dose Escalation Phase 1 Trial in 12-47 Month Old Children in Western Kenya to Evaluate the Safety and Immunogenicity of WRAIR's MSP-1(FMP1) Malaria Vaccine Adjuvanted in GSK's AS02A Versus Rabies Vaccine.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00317473
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:47.396461+00:00
Published At: 2017-10-02T00:00:00+00:00
Record Updated At: 2017-10-02
Results Posted At: 2017-10-02
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Plasmodium Falciparum Malaria"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2017-10-02"
protocolSection.identificationModule.nctId: "NCT00317473"
protocolSection.identificationModule.officialTitle: "Double-blind,Randomized,Controlled,Dose Escalation Phase 1 Trial in 12-47 Month Old Children in Western Kenya to Evaluate the Safety and Immunogenicity of WRAIR\u0027s MSP-1(FMP1) Malaria Vaccine Adjuvanted in GSK\u0027s AS02A Versus Rabies Vaccine."
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2017-10-02"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.